top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

17th Annual Bio Innovation Leaders Summit 2025

12th & 13th February 2025
Raffles Singapore

Jens H. Vogel

President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, Previous SVP & Global Biotech at Bayer is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jesse McCool, Co-Founder & CEO of Wheeler Bio is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Angela Vollstedt

Global R&D Director Cell & Gene Therapies Portfolio at Novartis

Angela Vollstedt, Global Director, Cell & Gene Therapies Portfolio Management at Novartis is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Behzad Mahdavi, CEO & Board Member at InnoGi Technologies #BILS is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Behzad Mahdavi

CEO & Board member at InnoGI Technologies & Executive Chairman at Open Cell Technologies

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza speaking at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
For the patients, we must do better.

Push boundaries, affect change

BILS 2025. The 17th Annual Bio Innovation Leaders Summit brings together c-suite, executives, pioneering thinkers and leading academics who are committed to breaking free from traditional silos to evolve and make an impact. Our curated programme is for leaders interested in strategy and innovation that will harness the full potential of the development of promising biologics and cell and gene therapies.  

 

Innovation Imperatives - Agenda Framework 

  • Lowering the cost of CAR T therapy by 10x

  • Optimising lentiviral-based immunotherapy manufacturing

  • New frontier for CDMO’s - forging strategic partnerships

  • Impact of automating and integrating AI, ML and data analytics

  • AI Driven platforms for immune cell therapy manufacturing

  • Antibody engineering and drug development for immuno oncology

  • Dynamic regulatory frameworks and harmonisation

  • Rise of modular and flexible facilities

  • Single-use and continuous bioprocessing innovation

  • Attracting, retaining and up-skilling talent

Impromptu testimonials

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Confirmed Speakers

Learn more

Register Interest

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Programme

​SPEAKERS